We are live on
!
Find out more
JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$45.3M
1-Year Est. Return
42.75%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$75.4M
AUM Growth
-$45M
(-37%)
Cap. Flow
-$46.2M
Cap. Flow
% of AUM
-61.28%
Top 10 Holdings %
Top 10 Hldgs %
98.02%
Holding
18
New
2
Increased
3
Reduced
10
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$1.03M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$839K |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$174K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kraft Heinz
KHC
|
+$46M |
| 2 |
AB InBev
BUD
|
+$12M |
| 3 |
CELG
Celgene Corp
CELG
|
+$343K |
| 4 |
UnitedHealth
UNH
|
+$337K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$215K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.75% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
Invesco QQQ Trust
QQQ
$455B
| $24.8M | 32.86% |
+180,000
| New | +$24.8M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $24.2M | 32.07% |
100,000
-100,000
| -50% | -$24M |
|
3
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
| $14.5M | 19.21% |
+350,000
| New | +$14.2M |
|
|
4
Incyte
INCY
$23.5B
| $2.93M | 3.89% |
23,300
+8,112
| +53% | +$1.03M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.75M | 2.32% |
19,264
-2,360
| -11% | -$215K |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $1.47M | 1.95% |
11,333
-2,798
| -20% | -$343K |
|
|
7
UnitedHealth
UNH
$382B
| $1.46M | 1.93% |
7,850
-1,922
| -20% | -$337K |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.31M | 1.73% |
10,743
+1,498
| +16% | +$174K |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.02M | 1.35% |
19,634
+13,201
| +205% | +$839K |
|
10
Eli Lilly
LLY
$1.07T
| $529K | 0.7% |
6,426
-1,543
| -19% | -$126K |
|
11
Regeneron Pharmaceuticals
REGN
$68.8B
| $472K | 0.63% |
961
-218
| -18% | -$95.4K |
|
12
Vertex Pharmaceuticals
VRTX
$121B
| $348K | 0.46% |
2,697
-642
| -19% | -$77.3K |
|
|
TSRO
13
DELISTED
TESARO, Inc.
TSRO
| $321K | 0.43% |
2,294
-566
| -20% | -$82K |
|
14
Neurocrine Biosciences
NBIX
$17.7B
| $271K | 0.36% |
5,890
-1,013
| -15% | -$49.1K |
|
15
CALL
iShares MSCI Brazil ETF
EWZ
$9.05B
| $79K | 0.1% |
2,300
-97,700
| -98% | -$3.51M |
|
|
16
AB InBev
BUD
$158B
| – | – |
-109,700
| Closed | -$12M |
|
|
17
PUT
iShares MSCI Brazil ETF
EWZ
$9.05B
| – | – |
-10,000
| Closed | -$375K |
|
|
18
Kraft Heinz
KHC
$30.4B
| – | – |
-506,888
| Closed | -$46M |
|
Similar funds
SM
PCM
NA
CG
OC
ICCON
CM
MCMC
JGP Global Gestao de Recursos's Q2 2017 Portfolio in Review
As of Q2 2017, JGP Global Gestao de Recursos held 18 positions worth $75.4M, down 37% from $120M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
JGP Global Gestao de Recursos withdrew a net $46.2M in Q2 2017, closing 3 positions and reducing 10 holdings. Its most notable exit was Kraft Heinz, an estimated $46M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 9.2% a quarter earlier, followed by Consumer Staples.
Against the trend, JGP Global Gestao de Recursos added an estimated $1.03M to Incyte.
- JGP Global Gestao de Recursos added most to Incyte in Q2 2017, an estimated $1.03M increase.
- JGP Global Gestao de Recursos's biggest Q2 2017 reduction was Celgene Corp, cutting an estimated $343K.
- JGP Global Gestao de Recursos fully exited Kraft Heinz in Q2 2017, selling an estimated $46M.
- JGP Global Gestao de Recursos's ten largest holdings make up 98% of its $75.4M portfolio in Q2 2017.
- JGP Global Gestao de Recursos opened 2 new positions and closed 3 in Q2 2017.
- JGP Global Gestao de Recursos's portfolio value fell 37% quarter-over-quarter to $75.4M.
Based on JGP Global Gestao de Recursos's 13F filing for Q2 2017, filed 4 Aug 2017.